By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
COVID345M88.69%
Other revenue37M9.51%
Respiratory syncytial virus (RSV)7M1.80%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.2B61.68%
Rest of world692M35.60%
Europe53M2.73%